{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:23:19Z","timestamp":1790266999808,"version":"4.1.0"},"reference-count":18,"publisher":"Wiley","issue":"11-12","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30CA016672"],"award-info":[{"award-number":["P30CA016672"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1111\/apt.13825","type":"journal-article","created":{"date-parts":[[2016,10,13]],"date-time":"2016-10-13T17:22:27Z","timestamp":1476379347000},"page":"1235-1241","source":"Crossref","is-referenced-by-count":50,"title":["Concomitant use of direct-acting antivirals and chemotherapy in hepatitis C virus-infected patients with cancer"],"prefix":"10.1111","volume":"44","author":[{"given":"M. P.","family":"Economides","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Infection Control and Employee Health; The University of Texas MD Anderson Cancer Center; Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Mahale","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Infection Control and Employee Health; The University of Texas MD Anderson Cancer Center; Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kyvernitakis","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Infection Control and Employee Health; The University of Texas MD Anderson Cancer Center; Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Turturro","sequence":"additional","affiliation":[{"name":"Department of Lymphoma\/Myeloma; The University of Texas MD Anderson Cancer Center; Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Kantarjian","sequence":"additional","affiliation":[{"name":"Department of Leukemia; The University of Texas MD Anderson Cancer Center; Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Naing","sequence":"additional","affiliation":[{"name":"Department of Investigational Cancer Therapeutics; The University of Texas MD Anderson Cancer Center; Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Hosry","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Infection Control and Employee Health; The University of Texas MD Anderson Cancer Center; Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. L.","family":"Shigle","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Clinical Programs; The University of Texas MD Anderson Cancer Center; Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kaseb","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Medical Oncology; The University of Texas MD Anderson Cancer Center; Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. A.","family":"Torres","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Infection Control and Employee Health; The University of Texas MD Anderson Cancer Center; Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,10,11]]},"reference":[{"key":"10.1111\/apt.13825-BIB0001|apt13825-cit-0001","unstructured":"AASLD\/IDSA\/IAS-USA Recommendations for testing, managing, and treating hepatitis C http:\/\/www.hcvguidelines.org"},{"key":"10.1111\/apt.13825-BIB0002|apt13825-cit-0002","first-page":"1","article-title":"Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965","volume":"61","author":"Smith","year":"2012","journal-title":"MMWR Recomm Rep"},{"key":"10.1111\/apt.13825-BIB0003|apt13825-cit-0003","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S1470-2045(02)00773-8","article-title":"Reactivation of replication of hepatitis B and C viruses after immunosuppressive therapy: an unresolved issue","volume":"3","author":"Vento","year":"2002","journal-title":"Lancet Oncol"},{"key":"10.1111\/apt.13825-BIB0004|apt13825-cit-0004","doi-asserted-by":"crossref","first-page":"41","DOI":"10.6004\/jnccn.2015.0007","article-title":"Effect of hepatitis C virus infection in patients with cancer: addressing a neglected population","volume":"13","author":"Torres","year":"2015","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1111\/apt.13825-BIB0005|apt13825-cit-0005","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/j.1478-3231.2007.01613.x","article-title":"Managing chronic hepatitis C in the difficult-to-treat patient","volume":"27","author":"Kemmer","year":"2007","journal-title":"Liver Int"},{"key":"10.1111\/apt.13825-BIB0006|apt13825-cit-0006","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/apt.13769","article-title":"The efficacy and safety of direct acting antiviral treatment and clinical significance of drug-drug interactions in elderly patients with chronic hepatitis C virus infection","volume":"44","author":"Vermehren","year":"2016","journal-title":"Aliment Pharm Ther"},{"key":"10.1111\/apt.13825-BIB0007|apt13825-cit-0007","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/apt.13514","article-title":"Review article: safety and tolerability of direct-acting anti-viral agents in the new era of hepatitis C therapy","volume":"43","author":"Banerjee","year":"2016","journal-title":"Aliment Pharm Ther"},{"key":"10.1111\/apt.13825-BIB0008|apt13825-cit-0008","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/hep.27920","article-title":"A clinician's guide to drug-drug interactions with direct-acting antiviral agents for the treatment of hepatitis C viral infection","volume":"63","author":"Dick","year":"2016","journal-title":"Hepatology"},{"key":"10.1111\/apt.13825-BIB0009|apt13825-cit-0009","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/cid\/civ973","article-title":"Drug-drug interactions with novel all oral interferon-free antiviral agents in a large real-world cohort","volume":"62","author":"Siederdissen","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1111\/apt.13825-BIB0010|apt13825-cit-0010","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S1473-3099(16)00118-3","article-title":"Management of viral hepatitis in patients with hematological malignancy in patients undergoing haematopoietic stem cell transplantation: recommendations of the 5th European Conference on Infections in Leukaemia (ECIL-5)","volume":"16","author":"Mallet","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1111\/apt.13825-BIB0011|apt13825-cit-0011","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1016\/j.bbmt.2015.07.033","article-title":"Hepatitis C virus infection among hematopoietic cell transplant donors and recipients: American society for blood and marrow transplantation task force recommendations","volume":"21","author":"Torres","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1111\/apt.13825-BIB0012|apt13825-cit-0012","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3109\/10428199509056828","article-title":"Hepatitis C virus serum markers and liver disease in children with leukemia","volume":"17","author":"Locasciulli","year":"1995","journal-title":"Leuk Lymphoma"},{"key":"10.1111\/apt.13825-BIB0013|apt13825-cit-0013","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2147\/JHC.S60867","article-title":"Telaprevir-containing regimen for treatment of hepatitis C virus infection in patients with hepatocellular carcinoma awaiting liver transplantation: a case series","volume":"1","author":"Torres","year":"2014","journal-title":"J Hepatocell Carcinoma"},{"key":"10.1111\/apt.13825-BIB0014|apt13825-cit-0014","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/apt.13633","article-title":"Systematic review: current concepts and challenges for the direct-acting antiviral era in hepatitis C cirrhosis","volume":"43","author":"Majumdar","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/apt.13825-BIB0015|apt13825-cit-0015","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/apt.13343","article-title":"Improvement of liver function parameters in advanced HCV-associated liver cirrhosis by IFN-free antiviral therapies","volume":"42","author":"Deterding","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/apt.13825-BIB0016|apt13825-cit-0016","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.bbmt.2015.12.010","article-title":"Hepatitis C virus infection in patients undergoing hematopoietic cell transplantation in the era of direct-acting antiviral agents","volume":"22","author":"Kyvernitakis","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1111\/apt.13825-BIB0017|apt13825-cit-0017","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1182\/blood-2016-05-718643","article-title":"How we treat hepatitis C virus infection in patients with hematologic malignancies","volume":"128","author":"Torres","year":"2016","journal-title":"Blood"},{"key":"10.1111\/apt.13825-BIB0018|apt13825-cit-0018","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1093\/annonc\/mdu166","article-title":"Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiane Linfomi","volume":"25","author":"Arcaini","year":"2014","journal-title":"Ann Oncol"}],"container-title":["Alimentary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fapt.13825","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/apt.13825\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T17:31:44Z","timestamp":1625419904000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/apt.13825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,11]]},"references-count":18,"journal-issue":{"issue":"11-12","published-print":{"date-parts":[[2016,12]]}},"URL":"https:\/\/doi.org\/10.1111\/apt.13825","archive":["Portico"],"relation":{},"ISSN":["0269-2813"],"issn-type":[{"value":"0269-2813","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10,11]]}}}